TheStormIsUponUs @stormis_us
@stormis_us
25 August, 10:55
FDA APPROVAL requires Pfizer to submit study results analyzing risk of myocarditis and pericarditis, and risk to long-term infant development in pregnant women.
Study results reports will be submitted to the FDA for review on Oct 31, 2025 and May 31, 2027 respectively.
Study results reports will be submitted to the FDA for review on Oct 31, 2025 and May 31, 2027 respectively.
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Only people mentioned by Paisley66 in this post can reply
